Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelin-positive Advanced Refractory Solid Tumors × fludarabine phosphate × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Myelodysplastic Syndromes 6 Multiple Myeloma 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Lymphoma, Non-Hodgkin 5 Hodgkin Disease 5 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Lymphoma, Follicular 3 Lymphoma, B-Cell 3 Lymphoma 3 Leukemia, Biphenotypic, Acute 3 Anemia, Refractory, with Excess of Blasts 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Plasma Cell 2 Leukemia, B-Cell 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Bone Marrow Failure Disorders 2 Adenocarcinoma of Lung 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uveal Melanoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡